Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye Episode 448: ZEISS Partners (OTC: $CZMWF) with Microsoft (NasdaqGS: $MSFT) for Digital Cloud Transformation, NVIDIA (NasdaqGS: $NVDA) Partners with GSK (NYSE: $GSK) for AI-Powered Discovery of Medicines and Vaccines

Wednesday, October 07, 2020

#AIEye Episode 448: ZEISS Partners (OTC: $CZMWF) with Microsoft (NasdaqGS: $MSFT) for Digital Cloud Transformation, NVIDIA (NasdaqGS: $NVDA) Partners with GSK (NYSE: $GSK) for AI-Powered Discovery of Medicines and Vaccines

#AIEye Episode 448: ZEISS Partners (OTC: $CZMWF) with Microsoft (NasdaqGS: $MSFT) for Digital Cloud Transformation, NVIDIA (NasdaqGS: $NVDA) Partners with GSK (NYSE: $GSK) for AI-Powered Discovery of Medicines and Vaccines

Global RPA Market to Reach $6.10 Billion by 2027

Point Roberts WA, Vancouver BC – October 7, 2020 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2020/100720-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2020/artificial-intelligence/10071AIEye-ZEISS-MSFT-NVDA-GSK.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTC:CZMWF) (NasdaqGS:MSFT) (NasdaqGS:NVDA) (NYSE:GSK)

Optics and optoelectronics manufacturer ZEISS Group (OTC:CZMWF) has entered a multi-year strategic partnership with Microsoft (NasdaqGS:MSFT) to accelerate its transformation into a digital services provider with a cloud first approach. In doing so, according to the press release, ZEISS will leverage Microsoft Azure’s “high-performance compute, AI, and IoT services,” “to provide original equipment manufacturers (OEMs) with new quality management solutions, enable microchip manufacturers to build more powerful, energy-efficient microchips, and deliver new digital healthcare solutions for improved clinical workflows, enhanced treatments, and device maintenance.” Karl Lamprecht, ZEISS President and CEO, commented:

"As a global leader in optics and optoelectronics, ZEISS is committed to digitally enable its customers' business models, products, and services. We are proud to join forces with Microsoft in our quest to apply precision optics, IoT capabilities, artificial intelligence and machine learning to the most demanding processes in healthcare and manufacturing. Improving the patient's life and doctor's work and driving industrial quality assurance in the production process have always been top of mind for us. We are taking our expertise to the next digital level together with Microsoft, a leading innovator and provider of digital technologies."

NVIDIA Corporation (NasdaqGS:NVDA) has announced a partnership with healthcare and pharmaceutical giant GlaxoSmithKline (NYSE:GSK) and its recently-established London-based AI hub, to aid in the discovery of medicines and vaccines. Kim Branson, senior vice president and global head of AI and ML at GSK, said:

“Because of the massive size of the datasets we use for drug discovery, we need to push the boundaries of hardware and develop new machine learning software. We’re building new algorithms and approaches in addition to bringing together the best minds at the intersection of medicine, genetics and artificial intelligence in the U.K.’s rich ecosystem. This new partnership with NVIDIA will also contribute additional computational power and state-of-the-art AI technology.”

Global RPA Market to Reach $6.10 Billion by 2027

A report published by Fortune Business Insights finds that the global Robotic Process Automation (RPA) market will grow from $1.03 billion in 2019 to $6.10 billion by 2027 with a compound annual growth rate (CAGR) of 24.9 percent in the forecast period 2020-2027. The following excerpt from the report summary outlines the role of AI adoption in driving the market:

Robotic process automation is in demand by organizations to handle complex unstructured information and automate any business functionality from end to end. Companies are combining artificial intelligence as well as cognitive technologies with RPA to extend the horizons of business process automation. These tools automatically observe the work activities, recognize optimal workflows, and suggest an automation path to the business.

RPA combined with artificial intelligence access unstructured information such as audio, video, and human chat conversation to make end-to-end automation possible.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com